PUBLIC COMPANY
saveF. Hoffmann-La Roche Ltd
updated 2mo ago
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.
community read0 votes
pipeline
30
marketed
9
phase 3
9
catalysts ytd
1
approvals ytd
1
recalls ytd
0
Pipeline(30)
view full pipeline →pipeline depth30 products
1Preclinical2Phase 19Phase 29Phase 39Marketed
Marketed
OSELTAMIVIR PHOSPHATE
Influenzavirus A Infections
Marketedalectinib
Non-Small Cell Lung Cancer
Marketedatezolizumab
Muscle Invasive Bladder Cancer (MIBC)
Programmed cell death 1 ligand 1
Marketedentrectinib
Non-Small Cell Lung Cancer
ALK tyrosine kinase receptorNeurotrophic tyrosine kinase receptor
Marketedfaricimab
Choroidal Neovascularization
Angiopoietin-2Vascular endothelial growth factor A, long form
Marketedglofitamab
Mantle Cell Lymphoma
B-lymphocyte antigen CD20T cell surface glycoprotein CD3
Marketedinavolisib
Human Epidermal Growth Factor Receptor 2 Positive Breast…
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
Marketedobinutuzumab
Systemic Lupus Erythematosus
B-lymphocyte antigen CD20
Marketedvemurafenib
Hairy Cell Leukemia
Serine/threonine-protein kinase B-raf
Phase 3CT-388
Obesity
Phase 3afimkibart
Crohn's Disease (Regional Enteritis)
Phase 3astegolimab
Chronic Obstructive Pulmonary Disease (COPD)
IL-33 receptor (ST2)
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that